• Explore /
  • Poster
  • / NEOSCOPE: A randomised Phase II study of induction chemotherapy followed by either oxaliplatin/capecitabine (OXCAP) or carboplatin/paclitaxel (CarPac) based chemoradiation (CRT) as pre-operative regimen for resectable oesophageal adenocarcinoma.

NEOSCOPE: A randomised Phase II study of induction chemotherapy followed by either oxaliplatin/capecitabine (OXCAP) or carboplatin/paclitaxel (CarPac) based chemoradiation (CRT) as pre-operative regimen for resectable oesophageal adenocarcinoma.

Abstract Poster

Authors

null

Somnath Mukherjee

University of Oxford, Oxford, United Kingdom

Somnath Mukherjee , Chris Hurt , Sarah Gwynne , Andrew Bateman , Simon Gollins , Ganesh Radhakrishna , Jo Canham , Ruby Ray , Heike I Grabsch , Ricky A. Sharma , Rhydian Maggs , Maria A Hawkins , David Sebag-Montefiore , Tim Maughan , Gareth Griffiths , Tom David Lewis Crosby

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2016 Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session A: Cancers of the Esophagus and Stomach

Track

Cancers of the Esophagus and Stomach

Sub Track

Multidisciplinary Treatment

Clinical Trial Registration Number

NCT01843829

Citation

J Clin Oncol 34, 2016 (suppl 4S; abstr 3)

DOI

10.1200/jco.2016.34.4_suppl.3

Abstract #

3

Poster Bd #

F3

Abstract Disclosures

Similar Posters

First Author: Thomas Crosby

First Author: Somnath Mukherjee

First Author: Cynthia G. Leichman

First Author: Darren Cowzer